Bonita David P

Average Profitability
<0.0001%
Insider Buys Quantity
9
Insider Buys Sum
$95.83M
Insider Sells Quantity
13
Insider Sells Sum
$4.19M

Insider Activity of Bonita David P

The largest purchase of all time was on 2020-09-25 and amounted to 2473600 shares of Prelude Therapeutics Incorporated for $47M.

The largest sale of all time was on 2021-08-17 and amounted to 34796 shares of Repare Therapeutics Inc. for $1.19M.

Biography of Bonita David P

No biography is available at this moment.

2023-05-22PurchasePrelude Therapeutics Incorporated
PRLD
869,565
1.9148%
$5.75$5M-30.53%
2022-06-22PurchaseIkena Oncology, Inc.
IKNA
23,419
0.0656%
$3.71$86,884+14.75%
2021-09-07SaleRepare Therapeutics Inc.
RPTX
director
887
0.0026%
$33.93$30,096-53.56%
2021-09-03SaleRepare Therapeutics Inc.
RPTX
director
7,197
0.0195%
$34.00$244,698-56.83%
2021-09-02SaleRepare Therapeutics Inc.
RPTX
director
16,424
0.0438%
$34.24$562,358-57.79%
2021-09-01SaleRepare Therapeutics Inc.
RPTX
director
12,968
0.035%
$33.98$440,653-56.98%
2021-08-31SaleRepare Therapeutics Inc.
RPTX
director
8,472
0.0228%
$33.94$287,540-56.97%
2021-08-30SaleRepare Therapeutics Inc.
RPTX
director
6,697
0.0183%
$33.92$227,162-56.25%
2021-08-27SaleRepare Therapeutics Inc.
RPTX
director
7,093
0.0192%
$33.94$240,736-56.49%
2021-08-26SaleRepare Therapeutics Inc.
RPTX
director
4,283
0.0121%
$34.52$147,849-55.38%
2021-08-25SaleRepare Therapeutics Inc.
RPTX
director
7,082
0.0188%
$34.34$243,196-57.68%
2021-08-24SaleRepare Therapeutics Inc.
RPTX
director
4,039
0.0109%
$34.07$137,609-56.56%
2021-08-23SaleRepare Therapeutics Inc.
RPTX
director
7,094
0.0192%
$34.06$241,622-56.26%
2021-08-18SaleRepare Therapeutics Inc.
RPTX
director
5,860
0.016%
$33.99$199,181-55.78%
2021-08-17SaleRepare Therapeutics Inc.
RPTX
director
34,796
0.0937%
$34.12$1.19M-56.42%
2021-03-30PurchaseIkena Oncology, Inc.
IKNA
director
423,400
6.8729%
$16.00$6.77M-49.34%
2021-01-11PurchasePrelude Therapeutics Incorporated
PRLD
83,400
$0$0-51.76%
2020-09-25PurchasePrelude Therapeutics Incorporated
PRLD
2.47M
56.1543%
$19.00$47M+48.63%
2020-08-21PurchasePrelude Therapeutics Incorporated
PRLD
2.07M
$0$0
2020-06-23PurchaseRepare Therapeutics Inc.
RPTX
director
1.55M
19.4779%
$20.00$30.97M-4.43%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.